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Objective. The overall aim with this study was to investigate causes of death and mortality rates for women and men
treated for abdominal aortic aneurysm (AAA) in Sweden.
Materials and method. All patients treated for ruptured and non-ruptured AAA 1987e2002 in Sweden were identified
in national registries (n¼ 12917). Age, sex, diagnosis, surgical procedure and mortality were analysed on a patient specific
level. Logistic regression and analysis of standardised mortality rates (SMR) were performed.
Results. Post operative mortality was similar between the sexes. Age (p< 0.0001), and surgery for rupture (p¼ 0.0005),
but not gender (p¼ 0.65) were significant risk factor for poor long term survival. SMR revealed increased risk for both
sexes compared to the population with significantly higher values for women than men (2.26, CI 2.10e2.43 vs. 1.63,
CI 1.57e1.68, p< 0.0001). The higher risk for women could be explained by the higher risk for aneurysm related death
(ie.thoracic or abdominal aorta) compared to men (Hazard ratio 1.57 vs. 1.0, p< 0.0001).
Conclusion. Women do not have an increased surgical risk compared to men, but treated women have an increased risk of
premature death compared to men and women in the population. They also have a higher risk for aneurysm related death
compared to men with AAA.
Keywords: Abdominal aortic aneurysm; Women; Mortality; Causes-of-death; Standardised mortality rate; Gender.Introduction
Obvious gender differences for patients with abdom-
inal aortic aneurysms (AAA) exist. Men are younger,
possibly have better outcome and represent a majority
in screening materials as well as reports on treated
patients.1e5
There is an overlap between occlusive and aneurys-
mal disease, patients with AAA commonly have man-
ifestations of atherosclerotic cardiovascular disease
and the AAA shares many risk factors with athero-
sclerosis.6e8 The percentage of females among patients
treated for occlusive cardiovascular disease has in-
creased the last decades, the reported unchanged
rate of women treated for AAA is therefore somewhat
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Outcome data for treated AAA patients are con-
flicting when analysed separately for women and
men. Women are sometimes reported to have poorer
postoperative survival, but the difference commonly
disappears after adjustment for age.4,12 Long term
survival can also be estimated as relative survival,
which implies a comparison considering age, and
when appropriate, sex matched populations. Norman
et al. reported that treated women had less favourable
relative survival than men, and concluded that this
should warrant increased attention towards clinical
management of women with AAA.13 Few reports
have responded to this appeal.
A different approach to analyse influential differ-
ences between men and women with AAA could be
to analyse causes of death in patients surviving the
postoperative period. Focus has previously been on
in-hospital rather than long term mortality, not only
when rates, but also when causes of death are ana-
lysed.1,2,14 An analysis of causes of death for womenrved.
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nerable postoperative period, could probably increase
our understanding of important causes for a possible
lower relative survival in women with AAA.
The aim of this study was to determine crude and
relative survival rates among women and men
treated for AAA in Sweden 1987e2002, and to inves-
tigate possible gender differences in their causes of
death.
Methods
Study population
The study cohort includes all patients (n¼ 12917)
treated with open repair or EVAR for non- ruptured
or ruptured abdominal aortic aneurysm (AAA) from
1987 to 1 November 2002 in Sweden. The Swedish
population was 8.9 million in 2001, 51% were women.
Data were extracted from the registry of the
National Board of Health and Welfare (NBHW).
The extraction of data was based on the procedural
codes for AAA, according to the ‘‘Classification of Sur-
gical Procedures’’ by the NBHW (edition 5, 6 and 7)
and the diagnostic codes for AAA classified by the
‘‘International Classification of Disease’’, ICD (edition,
9 and 10). The official code for classification of EVAR
was introduced in 1997. Separate analyses regarding
mortality data for EVAR patients were performed,
but are not presented in this article, due to few cases
(non-ruptured 5.5%, 13% women, ruptured <1%,
13% women).
Number of persons treated, age at treatment, sex
and procedural code were analysed on a patient spe-
cific level. Mean age for all treated persons increased
with 3.4 years during the observed period.
Mortality data (date of death, cause of death) for all
identified treated patients was extracted from the
‘‘Cause-of-Death’’ register (NBHW). To ascertain that
the follow up was minimum 60 days for all patients,
the data analysis includes patients treated in Sweden
until 1 November 2002. The subgroup ‘‘aneurysm re-
lated death’’ includes death by aneurysm or dissec-
tion in the thoracic or abdominal aorta (441 in ICD
9, I71 in ICD 10).
The present report focuses on long term survival,
i.e. 60 days after treatment. Sixty days rather than
the traditional 30 day mortality was used since previ-
ous experience revealed that all deaths associated
with the surgical procedure were not included in the
30 day mortality.15 Data for all deceased patients
within 60 days after treatment, i.e. postoperative mor-
tality, are excluded from the survival analysis.Statistics
The c2 test was used to compare nominal variables.
Mortality rates and causes of death were analysed
in a Cox regression model considering gender, rup-
ture vs non-rupture, age groups split in 10 year
groups, and calendar year (as presented in Tables 2
and 3). Results are presented as hazard ratios (HR)
together with 95% confidence intervals and Wald’s
test was used to assess statistical significance.
Test of two factor interactions between variables
included in the model were performed and no interac-
tions were found to be significant. The potential influ-
ence of residual confounding and deviations from the
proportional hazards assumption due to the relatively
coarse ageegroups was assessed by an alternative
model introducing five year age groups in a stratified
Cox regression allowing for different base-line
hazards depending of age at operation. This model
yielded essentially unchanged estimates. The propor-
tional hazard assumption was further investigated
by introduction of pseudo-time-dependent variables.
These analyses revealed that the differences in mortal-
ity between ruptured and non-ruptured aneurysm
was dependent of time since operation and the effect
of this variable was therefore also stratified of time
since operation.
The standardised mortality ratio (SMR) is a ratio
between the observed numbers of deceased persons
in the study population and the expected number of
deaths. The number of expected deaths was calcu-
lated by multiplying the numbers of person-years at
risk according to each 5-year age group, gender and
calendar year, by the corresponding age, gender and
year-specific mortality rates in the Swedish popula-
tion. Confidence intervals were computed assuming
Poisson distributed number of events.
Significance was defined as P< 0.05. This study
was approved by the regional Ethics Committee.
Results
Women treated for ruptured AAA had a higher post-
operative mortality than men but this difference
disappeared when adjustment for their higher age
was made (p¼ 0.85).
There was no difference in the mortality rate within
60 days between women and men treated for non-
ruptured AAA. Table 1.
Median survival for women surviving 60 days after
treatment for ruptured AAA was lower than for men
(6.2 vs 7.8 years). The long term survival rate for
women and men treated for non-ruptured AAA,Eur J Vasc Endovasc Surg Vol 33, May 2007
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for women and men (8.1 years vs. 8.2 years). Fig. 1.
A significantly higher mortality during follow up
was observed for all patients surviving surgery for
ruptured AAA compared to those operated electively.
This difference was most pronounced during the first
year. The hazard ratio for the months 3 to 6 was 1.82
(95% CI: 1.46e2.26), and decreased to 1.34 (95% CI:
1.00e1.80) during the second part of the first year.
One year or more after the operation the difference
was no longer significant; hazard ratio 1.07 (95% CI:
0.99e1.16).
Increasing age and treatment during the first calen-
dar years of the observation period were also impor-
tant risk factors for poor long term survival, but
gender was not. Table 2.
Standardised mortality rates
The observed long term mortality rate for all patients
treated for AAA was higher than for the Swedish
Table 1. Number of patients treated for ruptured and non-
ruptured AAA in Sweden 1987e2002 and mean age (standard
deviation). Number (percent) of deceased patients within 60
days after treatment for ruptured or non-ruptured AAA
Patients treated Deceased at
60 days
P
Ruptured
Men 72.1 ( 7.8) 3536 1447 (40.9) 0.05
Women 75.2 ( 7.3) 598 270 (45.1)
Non-ruptured
Men 70.2 ( 7.3) 7305 574 (7.9) 0.67
Women 71.7 ( 7.3) 1478 121 (8.2)
Chi square test used to compare differences in mortality rate
between women and men.
Fig. 1. Survival plot for patients surviving 60 days after sur-
gery treated for non ruptured or ruptured AAA.
Eur J Vasc Endovasc Surg Vol 33, May 2007population as a whole. Women operated for AAA
had significantly higher SMR than men. Patients
treated for ruptured AAA had a slightly higher SMR
when compared to patients treated for non-ruptured
AAA. Younger patients had a higher SMR. Table 3.
Causes of death
Causes of death during long termobservationwere dif-
ferently distributed when comparing women to men,
with a higher mortality from aneurysm related death
amongwomen. This cause of deathwas alsomore com-
monly found among patients treated for ruptured
AAA irrespective of death. Men more commonly
died from cancer related death than women. Table 4.
Discussion
The mortality rates were similar for women and men
after treatment for AAA, but women more commonly
Table 2. All cause mortality analysed in a Cox regression model
All cause
mortality
Hazard
Ratio
95% HR
Confidence limits
P
Men 1.00 reference 0.65
Women 1.02 0.94e1.10
Non-rupture 1.00 reference 0.0005
Rupture 1.13 1.06e1.22
Age group
<60 1.00 reference <0.0001
60e69 1.50 1.31e1.72
70e79 2.67 2.33e3.04
>80 4.21 3.60e4.92
Calendar year
1987e1990 1.00 reference 0.0004
1991e1994 0.90 0.84e0.97
1995e1998 0.89 0.81e0.97
1999e2002 0.76 0.66e0.87
Table 3. Standardised mortality rates (SMR). Expected cases are
based on mortality rates for the same age groups in the population
during the same time period
Observed
cases
Expected
cases
SMR CI P
Overall 4337 2536 1.71 1.66e1.76
Women 759 336 2.26 2.10e2.43 <0.0001
Men 3578 2200 1.63 1.57e1.68
Rupture 988 553 1.79 1.68e1.90 0.12
Non-rupture 3349 1983 1.69 1.63e1.75
Age group
<60 244 57 4.25 3.73e4.82 <00001
60e69 1210 531 2.28 2.15e2.41
70e79 2387 1481 1.61 1.55e1.68
>80 496 467 1.06 0.97e1.16
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pared to a matched population, both men and women
had an increased mortality and there was a significant
difference between the sexes with a higher standar-
dised mortality rate for women compared to men.
Few centres have the possibility to analyse outcome
data for the whole population on a patient specific
level. Lack of such resources result in smaller patient
materials and difficulties to analyse long term out-
come. The present study is one of the largest pop-
ulation based reports regarding outcome for treated
AAA patients. It confirms the often reported associa-
tion between the influence of increasing age and
mortality among these patients, but also that female
sex is not a risk for poor survival.2,4,12,13,15,16
In agreement with other authors the higher mortal-
ity rate demonstrated for women with ruptured AAA,
disappearswhen their higher age is considered.4,12,13,17
Some reports however, even recent ones, show contra-
dictory results regarding women’s survival even after
correction for their higher age.1,16,18,19 Differences in
‘‘case mix’’ and sources of data, population based vs
hospital records, can explain the finding of worse
outcome for women in these reports.
Increasing age as a predictor for poor survival is
commonly reported. A comparison with an age
matched population regarding survival, such as SMR,
rather than consideration of crude survival rates can,
however, be of greater value when a preventive treat-
ment for a lethal condition is considered. A high SMR
is a reflection of a discrepancy between a study popula-
tion and controls. The striking gender differences re-
garding SMR in our material is similar to findings by
Norman et al. evaluating 1475 Australian patients.13
Table 4. Causes of death analysed in a Cox regression model
Cause-of-death Hazard
ratio
95% HR
Confidence limits
P
Aneurysm specific
Men 1.00 reference <0.0001
Women 1.57 1.26e1.97
Non-rupture 1.00 reference <0.0001
Rupture 1.66 1.35e2.04
Cardiovascular death (excluding aneurysm specific)
Men 1.00 reference 0.30
Women 1.06 0.95e1.18
Non-rupture 1.00 reference 0.11
Rupture 1.09 0.98e1.20
Cancer
Men 1.00 reference 0.002
Women 0.74 0.61e0.90
Non-rupture 1.00 reference 0.29
Rupture 0.91 0.77e1.08Women with AAA die prematurely compared to
women in the population, to a greater extent than
men. The reported high prevalence of hypertension
and smokers among AAA patients, especially women,
can to some extent explain the high rate of premature
death.8,20 The present report adds death from other an-
eurysms as an explanation. Studies of mortality after
treatment reporting causes of death have mainly
focused on in-hospital mortality and usually lack sepa-
rate gender analysis.13,14,16,17,21,22 The few previous re-
ports describing risk factor profiles in AAA patients
with a gender perspective, commonly have too few
female cases to be analysed separately.8,20
The higher risk for women to die from aneurysm
related death (i.e. aneurysms in the thoracic or
abdominal aorta) has to our knowledge not been re-
ported previously. It can be hypothesised that the
higher risk of aneurysm related death among these
treated women is caused by thoracic aortic aneurysms
(TAA). A more equal distribution between the sexes
of TAA as compared to AAA has been described.23
Since these patients have been treated for aneurysmal
disease in the abdominal aorta, it is not unlikely that
‘‘aneurysm related death’’ is related to disease in the
thoracic aorta.
Patients treated for ruptured aneurysms obviously
have a continued decreased survival rate compared to
patients treated for non ruptured aneurysms at least
during the first year of treatment. They also have
a higher risk for aneurysm related death and possibly
a lower SMR than patients treated for non-ruptured
AAA. This indicates that they also have a less favour-
able risk factor profile or a more severe and different
disease than patients with non-ruptured AAA. Future
investigations should try to find possible explanations
for these differences, and if these patients should be
offered other investigations or preventive measures
after treatment.
Age at surgery influenced SMR probably due to
competing risk explaining the discrepancy between
expected and observed survival. The high SMR
observed in younger patients (<60 years of age) could
be explained by a long expected survival for the
control population, and that the study population
has a relatively large accumulation of risk factors,
otherwise they would not get the disease at an early
age. The low SMR among the elderly (>80 years)
has been shown by others13,24 and should probably
be interpreted as a reflection of a high mortality rate
in their age matched counterparts.
The limitations of registry based studies are well
recognised, such as the number of missing cases from
national registers. This would be a decreasing problem
in Sweden during the last decades, since the presentEur J Vasc Endovasc Surg Vol 33, May 2007
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to report treatedpatients inorder to receive funding.This
is also of minor concern when the main objective is to
compare differences between women and men.
The accuracy of procedural codes extracted from
the NBHW was very good when compared with
data from treated patient’s charts in 1970e1994.10
All data extracted from the Swedish NBHWare possi-
ble to analyse on a patient specific level which in-
creases the strength of the analysis performed. The
NBHW registry for mortality has a high validity and
very few deceased persons are missing.
The autopsy rate in Sweden is low (50% in 1970,
14% in 2002), which implies that all data on causes
of death must be analysed with caution. All deaths
are reported to the NBHW register by a physician,
most commonly with good knowledge of the de-
ceased patient. The low autopsy rate is thus not likely
to influence the distribution of causes of death differ-
ently between women and men.
Our results obviously highlight a patient group at
risk. Many questions regarding development of dis-
ease, expansion of aneurysms and risk for rupture in
AAA patients remain. It is highly likely that answers
found by enhancing our knowledge of gender differ-
ences regarding AAA will be applicable and useful
in the future care of both men and women with AAA.
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